<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4258300</article-id><article-id pub-id-type="pmid">25418933</article-id><article-id pub-id-type="publisher-id">6720</article-id><article-id pub-id-type="doi">10.1186/1471-2164-15-1015</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Key regulators in prostate cancer identified by co-expression module analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Jiang</surname><given-names>Junfeng</given-names></name><address><email>jf1986.jiang@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jia</surname><given-names>Peilin</given-names></name><address><email>peilin.jia@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhao</surname><given-names>Zhongming</given-names></name><address><email>zhongming.zhao@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Shen</surname><given-names>Bairong</given-names></name><address><email>bairong.shen@suda.edu.cn</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Center for Systems Biology, Soochow University, Jiangsu, China </aff><aff id="Aff2"><label/>Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37203 USA </aff><aff id="Aff3"><label/>Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232 USA </aff><aff id="Aff4"><label/>Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37212 USA </aff><aff id="Aff5"><label/>Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232 USA </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>15</volume><elocation-id>1015</elocation-id><history><date date-type="received"><day>8</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#169; Jiang et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Prostate cancer (PrCa) is the most commonly diagnosed cancer in men in the world. Despite the fact that a large number of its genes have been investigated, its etiology remains poorly understood. Furthermore, most PrCa candidate genes have not been rigorously replicated, and the methods by which they biologically function in PrCa remain largely unknown.</p></sec><sec><title>Results</title><p>Aiming to identify key players in the complex prostate cancer system, we reconstructed PrCa co-expressed modules within functional gene sets defined by the Gene Ontology (GO) annotation (biological process, GO_BP). We primarily identified 118 GO_BP terms that were well-preserved between two independent gene expression datasets and a consequent 55 conserved co-expression modules within them. Five modules were then found to be significantly enriched with PrCa candidate genes collected from expression Quantitative Trait Loci (eQTL), somatic copy number alteration (SCNA), somatic mutation data, or prognostic analyses. Specifically, two transcription factors (TFs) (NFAT and SP1) and three microRNAs (hsa-miR-19a, hsa-miR-15a, and hsa-miR-200b) regulating these five candidate modules were found to be critical to the development of PrCa.</p></sec><sec><title>Conclusions</title><p>Collectively, our results indicated that genes with similar functions may play important roles in disease through co-expression, and modules with different functions could be regulated by similar genetic components, such as TFs and microRNAs, in a synergistic manner.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/1471-2164-15-1015) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Prostate cancer</kwd><kwd>Co-expression</kwd><kwd>Gene Ontology</kwd><kwd>Module</kwd><kwd>Transcription factor</kwd><kwd>MicroRNA</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Prostate cancer (PrCa) is the sixth leading cause of cancer-related deaths of men in the world [<xref ref-type="bibr" rid="CR1">1</xref>] and the second leading cause in the United States [<xref ref-type="bibr" rid="CR2">2</xref>]. Due to the high risk of metastasis, it has become fundamentally important to uncover the underlying mechanisms of PrCa. Factors such as age, ethnicity, family history, heritability, diet, lifestyle, environment, and androgens have long been recognized as contributors to the risk of PrCa [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>]. As demonstrated by twin studies, PrCa&#8217;s genetic component is estimated to be as high as 42-57% [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p>To elucidate the underlying pathophysiology and molecular mechanisms of PrCa, numerous genetic and genomic studies have been conducted, including gene expression profiling [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>], expression Quantitative Trait Loci (eQTL) mapping [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref>], somatic copy number alteration (SCNA) identification [<xref ref-type="bibr" rid="CR16">16</xref>], gene mutation detection [<xref ref-type="bibr" rid="CR17">17</xref>], prognostic gene discovery [<xref ref-type="bibr" rid="CR18">18</xref>], microRNA (miRNA) expression profiling [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], and transcription factor (TF) enrichment [<xref ref-type="bibr" rid="CR20">20</xref>], among others. The gene expressions profiled by microarray technology have been a major strategy to detect mRNA abundance. Traditional, single, and gene-based strategies have been widely applied for gene expression analyses, but they suffered from limitations, such as multiple testing burdens [<xref ref-type="bibr" rid="CR21">21</xref>], small numbers of differentially expressed genes [<xref ref-type="bibr" rid="CR22">22</xref>], lack of interactions/regulations among genes [<xref ref-type="bibr" rid="CR23">23</xref>], or low replication rates [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p>Alternatively, gene co-expression module analysis attempts to study combined effects by identifying groups of genes that are coordinately expressed [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref>]. For instance, Horvath and colleagues have developed a widely used algorithm, the Weighed Gene Co-expression Network Analysis (WGCNA) [<xref ref-type="bibr" rid="CR28">28</xref>], to search for co-expression modules. The R package WGCNA implements a suite of tools for network construction, module detection, module significance examination, module preservation computation, and hub gene query, among many others [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>].</p><p>To our knowledge, no co-expression module has been constructed for the identification of key regulators in PrCa until now. Moreover, traditional co-expression studies that start from whole human genes on a chip (or top differentially expressed genes) often result in very large modules (e.g., &gt;1000 genes). Although functional assessments, such as GO enrichment, the functional gene/SNP enrichment test, and hub gene analysis could help to explore the functions of modules, such interpretation typically results in noisy results (e.g., a lot list of GO terms or genes). In this study, we developed a framework for gene co-expression module construction in PrCa using the WGCNA approach and augmented by Gene Ontology [<xref ref-type="bibr" rid="CR32">32</xref>] biological process (GO_BP) annotations. We argued that although GO_BP terms are broadly defined for each functional group, there may be subsets of genes in a biological process (GO_BP term) that are coordinately expressed, e.g., in a disease-associated fashion. For example, different co-expression modules may underlie different diseases, although they all execute the same biological functions as defined by GO_BP terms. To this end, we developed a systematic framework (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>) to search for co-expression modules within each GO_BP term and demonstrated it in PrCa. We primarily found 118 preserved GO_BP terms in two PrCa datasets and constructed 55 co-expression modules. We then assessed these modules for their enrichment of PrCa candidate genes collected by eQTLs, SCNA, somatic mutation data, or prognostic studies using the hypergeometric test. As a result, 5 modules were identified as significantly associated with PrCa, and several TFs and miRNAs were found to be potential key regulators of these candidate modules.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Overview of workflow. (A)</bold> GO-based gene co-expression network construction. It has five steps: (1) Raw microarray data processing and analysis. (2) GO term expression data matrix-building. (3) Pairwise correlation analysis of genes in GO term across different samples. (4) Expression profile clustering and module identification using WGCNA. (5) Visualization of co-expression modules by Cytoscape. <bold>(B)</bold> Framework of module significance analyses. The details are provided in Methods.</p></caption><graphic xlink:href="12864_2014_6720_Fig1_HTML" id="d30e403"/></fig></p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Processing and analysis of microarray gene expression data</title><p>Two microarray gene expression datasets were downloaded from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>). To ensure the data quality, we searched for studies that have a well-defined phenotypic description for PrCa, have a sample size around 100 or more, and have preferably been measured using similar platforms in order to obtain a high proportion of overlapping genes. We included both case and control samples to determine disease-specific signals, as similarly done in Chen <italic>et al</italic>. [<xref ref-type="bibr" rid="CR21">21</xref>]. Two datasets that fulfilled these criteria were downloaded for our further analyses (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The first dataset (GEO accession ID: GSE17951 [<xref ref-type="bibr" rid="CR33">33</xref>]), which was used as the training dataset in our work, was generated using the Affymetrix U133Plus2 array on prostate tissue samples from 109 cancer patients and 45 control samples [<xref ref-type="bibr" rid="CR33">33</xref>] (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The second dataset (GEO accession ID: GSE6956 [<xref ref-type="bibr" rid="CR10">10</xref>]), which was used as the testing dataset, was collected using the Affymetrix Human Genome U133A 2.0 array for 69 fresh-frozen prostate tumors and 20 control samples from surrounding normal prostate tissue [<xref ref-type="bibr" rid="CR10">10</xref>]. For each dataset, we performed the following quality control steps. First, outlier samples were detected and removed. We calculated the inter-array correlation (IAC) based on Pearson&#8217;s correlation coefficient for tumor and control samples, respectively. We excluded the samples with low mean IAC and/or those that emerged as a clear outlier by the hierarchical clustering approach [<xref ref-type="bibr" rid="CR34">34</xref>]. Second, samples were quantile-normalized after log<sub>2</sub> transformation [<xref ref-type="bibr" rid="CR35">35</xref>]. Probes with missing expression values in more than 30% samples were removed from further analyses. For each gene, we selected the probe with the highest intensity to represent the expression level of the gene. This resulted in 21,049 genes involved in 82 tumor and 40 control samples in the training dataset and 13,211 genes in 60 tumor and 19 normal samples in the testing dataset, with 13,211 genes shared by the two datasets.<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Summarization of PrCa microarray gene expression datasets used in the study</bold>
</p></caption><table-wrap-foot><p>
<sup>a</sup>QC: quality control.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Highly-preserved GO_BP terms</title><p>The GO database provides three annotation categories (domains): Molecular Function (MF), Biological Process (BP), and Cellular Component (CC). In this study, we focused on the BP category, based on the notion that genes that participate in the same biological processes tend to be expressed coordinately [<xref ref-type="bibr" rid="CR36">36</xref>]. We downloaded the GO_BP gene sets from the Molecular Signatures Database (MSigDB) [<xref ref-type="bibr" rid="CR37">37</xref>], including 825 GO_BP terms in the C5 category. To avoid too broadly or too narrowly defined GO_BP terms, we only kept the terms with 50 to 500 measured genes. As a result, 226 GO_BP terms were eligible to build the gene expression matrices for the following analysis.</p><p>Before the construction of the modules, we first evaluated the importance of each term associated with PrCa by calculating a preservation score. The preservation score aims to assess the level of preservation between the training and testing datasets for a gene set (i.e., a GO_BP term) and is typically measured based on both density and connectivity patterns among the genes [<xref ref-type="bibr" rid="CR29">29</xref>]. The parameter <italic>Z</italic><sub>summary</sub>[<xref ref-type="bibr" rid="CR29">29</xref>] implemented in WGCNA [<xref ref-type="bibr" rid="CR28">28</xref>] was employed to compute the preservation score. In general, a value of <italic>Z</italic><sub>summary</sub> &lt;2 indicates no evidence of preservation between the training and the testing datasets, 2&#8201;&lt;&#8201;<italic>Z</italic><sub>summary</sub> &lt;10 implies weak to moderate evidence, and <italic>Z</italic><sub>summary</sub> &gt;10 indicates strong evidence. At this stage, we aim to perform pre-selection of GO_BP terms that are suitable for the following co-expression clustering analysis. To this end, we chose a moderate threshold of preservation, <italic>Z</italic><sub>summary</sub> = 5 [<xref ref-type="bibr" rid="CR29">29</xref>], to select GO_BP terms and denote them as preserved GO_BP terms in both training and testing datasets.</p></sec><sec id="Sec5"><title>Application of WGCNA in PrCa</title><p>Given that genes within a GO_BP term are well-defined with similar biological functions, we asked whether they tend to co-express in a specific disease. Thus, we performed gene co-expression analysis for each preserved GO_BP term instead of all genes on the chip. We took the gene expression matrix for each GO_BP term as the input and applied WGCNA to detect co-expression modules. Gene co-expression correlation was measured by Pearson&#8217;s correlation coefficients. In this step, we built a pairwise co-expression matrix. This GO_BP term-based matrix was then utilized to construct an initial gene co-expression network by the <italic>blockwiseModules</italic> function in WGCNA. Notably, the initial co-expression network constructed and based only on Pearson&#8217;s correlation coefficients was not always a scale-free network. Rather, to obtain a scale-free network, a weighted adjacency matrix needs to be constructed using a selected power determined through a soft-thresholding approach in WGCNA.</p><p>Co-expression modules were then defined by a robust dynamic hierarchical tree cut algorithm using the measurement of dissimilarity (i.e., 1-topological overlap matrix) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. To ensure a suitable number of genes for next-step analysis, we set the minimum module size as 10. The adjacent modules were merged based on the parameter of cutHeight, i.e., modules with a minimum cutHeight at 0.25 were merged. Principle component analysis (PCA) of the expression matrix for each module was then performed. We denoted the first principal component (PC) as the module eigengene and used it to represent the overall expression profile of the module [<xref ref-type="bibr" rid="CR39">39</xref>]. For each gene, we computed a module membership (kME) based on the correlation between the gene expression and the module eigengene. Those genes with a lower membership (kME &#8804;0.3) were removed from the module and assigned to the grey module.</p><p>To validate whether the identified modules were associated with PrCa, we conducted a two-step evaluation procedure. First, for each module, we adopted the module eigengene to assess its trait association (denoted as <italic>p</italic><sub>cor</sub>) based on Pearson&#8217;s correlation coefficients. We used the false positive rate (FDR) for multiple testing correction [<xref ref-type="bibr" rid="CR40">40</xref>]. Second, for PrCa-associated modules, we further evaluated the module preservation in the testing dataset. Since the size of our identified module was generally less than 100, we defined a module to be preserved if it has a <italic>Z</italic><sub>summary</sub> (module) &gt;5.</p></sec><sec id="Sec6"><title>Enrichment test</title><p>Four types of large-scale, PrCa-associated genetic/genomic data, eQTL genes, recurrent SCNAs, somatic mutations, and prognostic genes were collected for the enrichment test of the identified modules. The eQTL genes were collected from the online eQTL database, SeeQTL (<ext-link ext-link-type="uri" xlink:href="http://www.bios.unc.edu/research/genomic_software/seeQTL/">http://www.bios.unc.edu/research/genomic_software/seeQTL/</ext-link>), which re-analyzed nine independent HapMap studies in lymphoblastoid cell lines (LCLs); performed a consensus meta-analysis with comprehensive quality control, population stratification control, and FDR control; and provided the q-value as the significance measurement [<xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR47">47</xref>]. We retrieved a total of 8652 genes regulated by <italic>cis-</italic>eQL (7071 genes) or <italic>trans-</italic>eQTL (4140 genes) from the SeeQTL database. Here, <italic>cis</italic>-eQTL represents the cases where the regulated genes are located within 1&#160;Mb of the regulatory SNP, while <italic>trans</italic>-eQTL indicates associations for more distant eQTL. We denoted them as <italic>cis-</italic>eQTL and <italic>trans-</italic>eQTL gene sets, respectively.</p><p>A list of PrCa susceptibility genes located in SCNA regions was downloaded from the cBio data portal [<xref ref-type="bibr" rid="CR48">48</xref>]. These SCNA regions were obtained using GISTIC2 (q-value &lt;0.1) [<xref ref-type="bibr" rid="CR49">49</xref>], based on The Cancer Genome Atlas (TCGA) prostate adenocarcinoma data (<ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link>). In sum, we retrieved 567 unique genes and denoted them as the SCNA gene set.</p><p>Genes with somatic mutations were collected from two sources. First, we manually collected 47 mutated genes from the Human Prostate Gene Database (PGDB) [<xref ref-type="bibr" rid="CR17">17</xref>]. Second, 107 significantly mutated genes identified in the TCGA prostate adenocarcinoma (<ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link>) samples were retrieved from the cBio portal. As a result, we obtained 149 unique genes and denoted them as the mutant gene set.</p><p>We downloaded the RNASeqV2 and clinical data for prostate adenocarcinoma from the TCGA portal (<ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link>). The Univariate Cox model was applied to define the prognostic genes [<xref ref-type="bibr" rid="CR18">18</xref>]. FDR was applied for multiple testing correction of the raw Wald <italic>p</italic> values. Finally, we obtained 737 genes with FDR&#8201;&lt;&#8201;0.05.</p><p>Gene set enrichment analysis for PrCa-associated modules was performed using the hypergeometric test. Multiple testing correction was controlled by the FDR method. The module was taken as a candidate if it significantly enriched with any of the two gene sets among eQTL, SCNA, mutation, and prognostic genes with FDR&#8201;&lt;&#8201;0.05. We further performed enrichment tests of the candidate module genes with TF and miRNA using the online tool WebGestalt [<xref ref-type="bibr" rid="CR50">50</xref>]. The resultant <italic>p</italic> values were corrected for multiple testing using the FDR method. We set the significance level for FDR at 0.01 and the minimum number of genes for a category at two. For simplification, the top 5 enriched TFs or miRNAs were collected for further analyses.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>The identified GO_BP-based co-expression modules</title><p>GO_BP terms categorize genes that function in the same or similar biological processes. Hence, genes in the same GO_BP term could be expected to have coordinated expression patterns. In our study, among the 226 GO_BP terms that fulfilled our query criteria (size between 50 and 500), 118 had a preservation score of <italic>Z</italic><sub>summary</sub> (GO_BP) &gt;5 and were considered well preserved between the training and the testing datasets. For each of these 118 GO_BP terms, we built a weighted co-expression network using the entire training dataset of 82 prostate tumor samples and 40 control samples (see Methods). Highly co-expressed genes within a term were then clustered into modules, each labeled with a specific color (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>A4). This resulted in 548 modules in total. To examine their association with prostate cancer, we calculated the correlation between the module expression profiles (represented by the module eigengene) and the PrCa disease status (represented by a vector of 1 for case and 0 for control). With FDR &lt;0.05, we identified 294 of the 548 modules that showed statistically significant association with PrCa in the training dataset. To further evaluate the association, we calculated the preservation score, <italic>Z</italic><sub>summary</sub>, for each single module against the testing dataset. 55 of the 294 modules were preserved with <italic>Z</italic><sub>summary</sub> (module) &gt;5. As shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1, these 55 modules belong to 35 GO_BP terms. Many of these terms have been reported to be associated with cancer development, such as &#8220;biosynthetic process&#8221; [<xref ref-type="bibr" rid="CR18">18</xref>], &#8220;cell-cell signaling&#8221; [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], &#8220;inflammatory response&#8221; [<xref ref-type="bibr" rid="CR53">53</xref>], &#8220;response to stress&#8221; [<xref ref-type="bibr" rid="CR54">54</xref>], &#8220;post translational protein modification&#8221; [<xref ref-type="bibr" rid="CR55">55</xref>], &#8220;immune system process&#8221; [<xref ref-type="bibr" rid="CR56">56</xref>], &#8220;phosphorylation&#8221; [<xref ref-type="bibr" rid="CR57">57</xref>], &#8220;regulation of apoptosis&#8221; [<xref ref-type="bibr" rid="CR58">58</xref>], and &#8220;regulation of cell proliferation&#8221; [<xref ref-type="bibr" rid="CR59">59</xref>] in many cancer types, including PrCa. Although expected, these results confirmed that the identified modules are important to PrCa, and the method for the analysis is reasonable. In addition, the successful detection indicates that there are indeed subsets of genes within each single GO_BP term that are co-expressed and associated with PrCa. This further verified the rationale of our procedure to examine co-expression patterns in each GO_BP term, rather than in the whole gene set on chip, and proved its ability to discover disease-associated genes and modules.</p></sec><sec id="Sec9"><title>Characterization of the identified PrCa associated modules</title><p>Our enrichment test of the 55 preserved PrCa-associated modules showed that six modules were significantly enriched with PrCa candidate genes, such as eQTL, SCNA, or mutant genes (FDR adjusted <italic>p</italic>&#8201;&lt;&#8201;0.05) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Their functions are annotated as &#8220;response to stress (labeled in green in Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>A4)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 0.017, <italic>p</italic><sub><italic>trans</italic>-eQTL</sub> = 3.16&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>mutation</sub> = 1.37&#8201;&#215;&#8201;10<sup>&#8722;3</sup>), &#8220;cellular localization (turquoise)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 7.30&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>SCNA</sub> = 0.024, <italic>p</italic><sub>prog</sub> =1.62&#8201;&#215;&#8201;10<sup>&#8722;3</sup>), &#8220;protein localization (brown)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 0.034, <italic>p</italic><sub>SCNA</sub> = 0.039, <italic>p</italic><sub>mutation</sub> = 6.84&#8201;&#215;&#8201;10<sup>&#8722;4</sup>), &#8220;regulation of apoptosis (green)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 8.93&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>SCNA</sub> = 0.040), &#8220;regulation of apoptosis (red)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 0.027, <italic>p</italic><sub><italic>trans</italic>-eQTL</sub> = 6.59&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>mutation</sub> = 6.39&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), and &#8220;apoptosis go (black)&#8221; (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub> = 8.93&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub><italic>trans</italic>-eQTL</sub> = 1.08&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>mutation</sub> = 6.41&#8201;&#215;&#8201;10<sup>&#8722;5</sup>). We calculated the pairwise similarities between the six modules using Fisher&#8217;s exact test. As a result, &#8220;regulation of apoptosis (red)&#8221; and &#8220;apoptosis go (black)&#8221; were found with a large proportion of overlapping genes (<italic>p</italic>&#8201;=&#8201;3. 7&#8201;&#215;&#8201;10<sup>&#8722;41</sup>). We therefore merged these two modules and referred to the resultant module as M1. Other modules were listed as M2-M5, as summarized in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Overview of enrichment analyses of the five identified PrCa modules</bold>
</p></caption><table-wrap-foot><p>
<sup>a</sup>
<italic>p</italic> values were adjusted by FDR method.</p></table-wrap-foot></table-wrap></p><p>For these identified PrCa-associated modules, we recalculated the Module Membership (kME) of each gene by its correlation with the module eigengene (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2). In particular, we presented the five modules in Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>, in which nodes were ranked by their kME values and edge thickness reflected the correlations&#8217; coefficients. Node shapes represented different gene functions, as shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2. Genes with higher kME values were highly interconnected in modules M1, M3, and M4, indicating a strong co-expression pattern in PrCa (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>). In modules M2 and M5, relatively moderate connections were observed. This is likely due to a weak PrCa association (M2, <italic>p</italic><sub>cor</sub> = 0.015) or a low preservation score (M5, <italic>Z</italic><sub>summary</sub> = 5.2). The biological functions of modules M1 and M2 are associated with the GO_BP term &#8220;apoptosis.&#8221; Representative genes include <italic>IL6</italic>[<xref ref-type="bibr" rid="CR60">60</xref>], <italic>SOCS3</italic>[<xref ref-type="bibr" rid="CR61">61</xref>], <italic>GADD45A</italic>[<xref ref-type="bibr" rid="CR62">62</xref>], <italic>PIM1</italic>[<xref ref-type="bibr" rid="CR63">63</xref>], <italic>1L1B</italic>[<xref ref-type="bibr" rid="CR64">64</xref>], <italic>CDKN1A</italic>[<xref ref-type="bibr" rid="CR65">65</xref>], <italic>CCL2</italic>[<xref ref-type="bibr" rid="CR66">66</xref>], <italic>PMAIP1</italic> (also known as <italic>NOXA</italic>) [<xref ref-type="bibr" rid="CR67">67</xref>], and <italic>RHOB</italic>[<xref ref-type="bibr" rid="CR68">68</xref>] in module M1, and <italic>DHCR24</italic>[<xref ref-type="bibr" rid="CR69">69</xref>], <italic>BNIP3</italic>[<xref ref-type="bibr" rid="CR70">70</xref>], and <italic>IGF1R</italic>[<xref ref-type="bibr" rid="CR71">71</xref>] in module M2. For modules M3, M4, and M5, although the corresponding GO_BP terms were not directly related to cancer, we found PrCa-relevant genes in these three modules, including <italic>BTG2</italic>[<xref ref-type="bibr" rid="CR72">72</xref>], <italic>FOS</italic> (also known as <italic>c-Fos</italic>) [<xref ref-type="bibr" rid="CR73">73</xref>], and <italic>CXCR4</italic>[<xref ref-type="bibr" rid="CR74">74</xref>] in module M3; <italic>ARFGAP3</italic>[<xref ref-type="bibr" rid="CR75">75</xref>] and <italic>CDH1</italic>[<xref ref-type="bibr" rid="CR76">76</xref>] in module M4; and <italic>SMAD3</italic>[<xref ref-type="bibr" rid="CR77">77</xref>] and <italic>MXI1</italic>[<xref ref-type="bibr" rid="CR78">78</xref>] in module M5.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Visualization of the five identified PrCa-associated modules.</bold> To better describe the modules, we ranked nodes by their module membership (kME) values, and the edge widths are proportional to their correlations. Legends are listed at the bottom for clarity.</p></caption><graphic xlink:href="12864_2014_6720_Fig2_HTML" id="d30e1570"/></fig></p><p>Moreover, we identified TF and microRNA regulators enriched in the modules, and the results are shown in Table&#160;<xref rid="Tab3" ref-type="table">3</xref>. Some TFs could be seen as associated with several modules. For example, modules M1 and M3 were significantly enriched with the nuclear factor of activated T-cell transcription factor gene, <italic>NFAT</italic> (<italic>p</italic><sub>M1</sub>&#8201;=&#8201;3.59&#8201;&#215;&#8201;10<sup>&#8722;7</sup>, <italic>p</italic><sub>M3</sub>&#8201;=&#8201;2.20&#8201;&#215;&#8201;10<sup>&#8722;5</sup>). All the other three modules&#8212;M2, M4, and M5&#8212;were significantly enriched with the gene specificity protein 1, <italic>SP1</italic> (<italic>p</italic><sub>M2</sub>&#8201;=&#8201;3.00&#8201;&#215;&#8201;10<sup>&#8722;4</sup>, <italic>p</italic><sub>M4</sub>&#8201;=&#8201;4.00&#8201;&#215;&#8201;10<sup>&#8722;4</sup>, <italic>p</italic><sub>M5</sub>&#8201;=&#8201;1.20&#8201;&#215;&#8201;10<sup>&#8722;3</sup>) (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>). Both <italic>NFAT</italic> and <italic>SP1</italic> were known to be associated with PrCa [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].<table-wrap id="Tab3"><label>Table 3</label><caption><p>
<bold>Transcription factors (TFs) and microRNAs (miRNAs) identified by the analyses of PrCa-associated modules (M1-M5)</bold>
</p></caption><table-wrap-foot><p>TFs and miRNAs in italics were those shared between modules and associated with prostate cancer.</p><p>
<sup>a</sup>
<italic>p</italic> values were adjusted by FDR method.</p></table-wrap-foot></table-wrap></p><p>To further search for evidence of the coordinated regulation of each identified module, we explored the module eigengene in tumor and control samples for all five modules. As shown in Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>, the eigengenes of modules M1, M2, M3, and M4 were consistently over-expressed in PrCa tumor samples compared to control samples, while the eigengene of module M5 was under-expressed. These observations implied that the module genes might be co-regulated by the same or similar regulators, e.g., TFs (or their regulators) or miRNAs that regulate the expression of the module genes. We therefore examined the correlation between the candidate TFs (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>) with PrCa. Specifically, the TF NFAT family genes, such as <italic>NFATC4</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;8.94&#8201;&#215;&#8201;10<sup>&#8722;7</sup>, <italic>p</italic><sub>cor2</sub>&#8201;=&#8201;7.66&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) and <italic>NFATC1</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;2.25&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>cor2</sub>&#8201;=&#8201;3.61&#8201;&#215;&#8201;10<sup>&#8722;2</sup>), were associated with PrCa. The activation of partner gene <italic>TRPV6</italic> was reported to be critical to NFAT [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] in prostate cancer cells. Our specific examination showed that <italic>TRPV6</italic> was significantly over-expressed in PrCa tumor samples (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;6.49&#8201;&#215;&#8201;10<sup>&#8722;6</sup>) in the training dataset, but not in the testing dataset (<italic>p</italic><sub>cor2</sub>&#8201;=&#8201;0.12). In addition, other enriched TFs showed promising evidence (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>) for association with PrCa, such as <italic>SP1</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;4.60&#8201;&#215;&#8201;10<sup>&#8722;7</sup> and <italic>p</italic><sub>cor2</sub>&#8201;=&#8201;7.50&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), <italic>REL</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;8.08&#8201;&#215;&#8201;10<sup>-10,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;0.010), and <italic>JUN</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;5.91&#8201;&#215;&#8201;10<sup>-15,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;7.70&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) in module M1; <italic>RFX1</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;3.67&#8201;&#215;&#8201;10<sup>-5,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;3.10&#8201;&#215;&#8201;10<sup>&#8722;6</sup>), <italic>VSX1</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;1.55&#8201;&#215;&#8201;10<sup>-4,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;0.036), and <italic>RORA</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;1.29&#8201;&#215;&#8201;10<sup>-3,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;3.15&#8201;&#215;&#8201;10<sup>&#8722;11</sup>) in module M2; <italic>NF1</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;1.14&#8201;&#215;&#8201;10<sup>-3,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;6.01&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) in module M4; and <italic>CDC5L</italic> (<italic>p</italic><sub>cor1</sub>&#8201;=&#8201;0.012<sup>,</sup><italic>p</italic><sub>cor2</sub>&#8201;=&#8201;8.07&#8201;&#215;&#8201;10<sup>&#8722;6</sup>) in module M5.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Expression of module eigengenes in five modules (M1-M5) across samples.</bold> Blue indicates tumor samples, while red indicates control samples.</p></caption><graphic xlink:href="12864_2014_6720_Fig3_HTML" id="d30e2912"/></fig></p><p>In Table&#160;<xref rid="Tab3" ref-type="table">3</xref>, we listed the enriched miRNAs; several of them have been reported to be associated with PrCa, such as hsa-miR-19a [<xref ref-type="bibr" rid="CR82">82</xref>] with modules M1 and M3 (<italic>p</italic><sub>M1</sub>&#8201;=&#8201;3.50&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic>M3&#8201;=&#8201;6.10&#8201;&#215;&#8201;10<sup>&#8722;3</sup>), hsa-miR-15a [<xref ref-type="bibr" rid="CR83">83</xref>] with modules M4 and M5 (<italic>p</italic><sub>M4</sub>&#8201;=&#8201;4.70&#8201;&#215;&#8201;10<sup>&#8722;3</sup>, <italic>p</italic><sub>M5</sub>&#8201;=&#8201;3.00&#8201;&#215;&#8201;10<sup>&#8722;4</sup>), and hsa-miR-200b [<xref ref-type="bibr" rid="CR84">84</xref>] with module M2 (<italic>p</italic><sub>M2</sub>&#8201;=&#8201;9.00&#8201;&#215;&#8201;10<sup>&#8722;3</sup>). For the other microRNAs, experimental validation is needed to investigate their roles in PrCa.</p><p>In order to validate the regulatory TFs/miRNAs detected above, we retrieved RNASeqV2 and miRNASeq data for prostate adenocarcinoma from the TCGA portal to build the expression matrix. The R package edgeR [<xref ref-type="bibr" rid="CR85">85</xref>] was applied to obtain the differentially expressed genes and miRNAs. The FDR method was applied to adjust <italic>p</italic> values for multiple testing. We found that the identified key TF regulators, including NFAT family genes (<italic>p</italic><sub>NFATC4</sub>&#8201;=&#8201;7.85&#8201;&#215;&#8201;10<sup>&#8722;12</sup>, <italic>p</italic><sub>NFAT5</sub>&#8201;=&#8201;6.76&#8201;&#215;&#8201;10<sup>&#8722;6</sup>, <italic>p</italic><sub>NFATC2</sub>&#8201;=&#8201;6.79&#8201;&#215;&#8201;10<sup>&#8722;6</sup>, <italic>p</italic><sub>NFATC3</sub>&#8201;=&#8201;6.95&#8201;&#215;&#8201;10<sup>&#8722;3</sup>), NFAT regulator TRPV6 (<italic>p</italic>&#8201;=&#8201;1.40&#8201;&#215;&#8201;10<sup>&#8722;6</sup>), and SP1 (<italic>p</italic>&#8201;=&#8201;9.49&#8201;&#215;&#8201;10<sup>&#8722;3</sup>), were highly differentially expressed, as well as the other enriched TFs, such as REL (<italic>p</italic>&#8201;=&#8201;1.35&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), RORA (<italic>p</italic>&#8201;=&#8201;1.54&#8201;&#215;&#8201;10<sup>&#8722;13</sup>), and NF1 (<italic>p</italic>&#8201;=&#8201;6.24&#8201;&#215;&#8201;10<sup>&#8722;4</sup>). Similar patterns were also observed in the identified miRNAs, such as hsa-miR-19a (<italic>p</italic>&#8201;=&#8201;1.72&#8201;&#215;&#8201;10<sup>&#8722;12</sup>), hsa-miR-15a (<italic>p</italic>&#8201;=&#8201;8.10&#8201;&#215;&#8201;10<sup>&#8722;10</sup>), and hsa-miR-200b (<italic>p</italic>&#8201;=&#8201;6.39&#8201;&#215;&#8201;10<sup>&#8722;3</sup>).</p></sec></sec><sec id="Sec10"><title>Discussion</title><p>High-throughput genetic and genomic studies have demonstrated that GO terms are important prior knowledge in facilitating and interpreting of discoveries in complex disease studies. In this study, we identified gene co-expression modules within GO_BP terms for PrCa. We found 118 GO_BP terms that were preserved between training and testing datasets, some of them have been widely studied and reported, such as &#8220;programmed cell death&#8221; [<xref ref-type="bibr" rid="CR86">86</xref>], &#8220;cell-cell adhesion&#8221; [<xref ref-type="bibr" rid="CR87">87</xref>], and &#8220;regulation of apoptosis&#8221; [<xref ref-type="bibr" rid="CR87">87</xref>]. We applied WGCNA to the PrCa expression data sets and identified five co-expression modules which were preserved in the training and testing datasets and enriched with known PrCa genes. In our further evaluation of these modules, we identified several PrCa associated TFs and miRNAs as putative key regulators in PrCa genesis and progression.</p><p>To evaluate the performance of our approach, we applied another popular co-expression network reconstruction algorithm, K-means [<xref ref-type="bibr" rid="CR88">88</xref>], to the GO_BP-based expression matrices. For each GO_BP term, the number of modules obtained from WGCNA was assigned to K-means. Among the 548 constructed modules, only 12 modules showed significant association with PrCa status (FDR&#8201;&lt;&#8201;0.05) and were preserved in the testing dataset (<italic>Z</italic><sub>summary</sub>&#8201;&gt;&#8201;5). Further enrichment tests showed that these 12 modules were poorly enriched in the collected PrCa genes (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S3). Since the module preservation calculation is computationally time-consuming, we did not perform other algorithms for comparison. Although more comparison with other methods may be needed, the WGCNA approach seems to be effective on detecting the risk modules for PrCa.</p><p>The results revealed that the co-expression modules that belong to known cancer-related GO terms could play regulatory roles in PrCa, such as the two apoptosis-related candidate modules, M1 and M2. The results also indicated that those modules associated with general terms, e.g., &#8220;response to stress,&#8221; &#8220;cellular localization,&#8221; and &#8220;protein localization,&#8221; may contribute to PrCa risk in a synergistic way. As a core signaling pathway in cancers [<xref ref-type="bibr" rid="CR89">89</xref>&#8211;<xref ref-type="bibr" rid="CR92">92</xref>], apoptosis-blocking has proven to be very important in cell development [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR93">93</xref>] during the stages of progression from normal epithelial cells, to androgen-dependent tumor cells, and further to malignant androgen-independent ones. On the other hand, cells can be activated in various ways in response to stress during cell development, mainly to maintain the balance between cell death and cell proliferation [<xref ref-type="bibr" rid="CR94">94</xref>]. Therefore, cells that experience too much stress, e.g., an over-expressed module M3, may bring down the rate of cancer cell death and thus result in the formation of cancer [<xref ref-type="bibr" rid="CR95">95</xref>&#8211;<xref ref-type="bibr" rid="CR97">97</xref>]. As indicated by previous studies [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>], we then considered that the alternation of expression for genes involved in cellular and protein localizations play critical roles during cell-division and cancer cell proliferation, such as through modules M4 and M5; studying the localizations of these genes and their encoded proteins can help us elucidate the molecular basis of cancer genesis and progression [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>].</p><p>As we found, different modules may share the same genetic regulator, such as TF and miRNA. An intriguing example is the TF, NFAT, enriched by both modules M1 and M3. NFAT is reported to promote the epithelial cell proliferation of human primary PrCa [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] with store-independent Ca<sup>2+</sup> entry via the TRPV6 channel. Significant expression changes of NFAT family genes and their regulator <italic>TRPV6</italic> were observed in PrCa in the datasets. Another TF, SP1, was found to be PrCa-associated and enriched in three modules: M2, M4, and M5. SP1 has been considered an important target for PrCa therapy, since it regulates important genes, like the androgen receptor gene (<italic>AR</italic>), <italic>TGF-&#946;, c-Met</italic> and prostate specific antigen (<italic>PSA</italic>), and others. These genes are involved in cell cycle, proliferation, cell differentiation, and apoptosis [<xref ref-type="bibr" rid="CR80">80</xref>]. Other enriched TFs, STAT1 and NFKB [<xref ref-type="bibr" rid="CR102">102</xref>], and moderately enriched miRNAs, hsa-miR-15a [<xref ref-type="bibr" rid="CR83">83</xref>] and hsa-miR-19a [<xref ref-type="bibr" rid="CR82">82</xref>] (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>), are also reported to be associated with PrCa. Similar expression patterns were also observed in another independent TCGA dataset. Taken together, our findings suggested that these 5 modules and their TF and microRNA regulators are likely critical for the genesis and progression of PrCa. These modules and regulators may be molecular targets for the future development of drugs and new therapies.</p><p>In this study, we chose a relatively stringent significance level to detect candidate modules. The identified modules need to be enriched with both eQTL genes and SCNA or mutated genes, with a corrected <italic>p</italic> &lt;0.05. This might exclude moderately associated modules (e.g., <italic>p</italic> &lt;0.2), such as &#8220;response to chemical stimulus (in turquoise in Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>A4) (<italic>p</italic><sub><italic>trans</italic>-eQTL</sub>&#8201;=&#8201;0.086, <italic>p</italic><sub>SCNA</sub>&#8201;=&#8201;0.062),&#8221; &#8220;regulation of apoptosis (turquoise) (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub>&#8201;=&#8201;0.075, <italic>p</italic><sub>SCNA</sub>&#8201;=&#8201;0.039),&#8221; and &#8220;apoptosis go (turquoise) (<italic>p</italic><sub><italic>cis</italic>-eQTL</sub>&#8201;=&#8201;0.071, <italic>p</italic><sub>SCNA</sub>&#8201;=&#8201;0.024)&#8221; (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p><p>In summary, our findings indicate that genes with same GO functions can cluster into several co-expressed modules to contribute to PrCa, as seen in modules M1 and M2. Modules across GO terms may act in the networks that are regulated by same genetic factors, such as modules M1 and M3. These findings indicate the importance of studying PrCa development at a systems level rather than at a single-gene level, offering insights into the underlying mechanisms of PrCa.</p></sec><sec id="Sec11"><title>Conclusions</title><p>Using GO_BP terms to start, we conducted gene co-expression analysis of expression profiles of PrCa. Our results revealed five modules that were differentially expressed between tumors and controls, preserved between independent expression datasets, and enriched with putative cancer genes. The enrichment analyses further identified TF and miRNA as key regulators in PrCa. Our study provides important insights for the future investigation of molecular functionality related to PrCa etiology and the development of PrCa diagnosis tools and targeted therapy strategies.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec12"><supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12864_2014_6720_MOESM1_ESM.docx"><caption><p>Additional file 1: Table S1.: Enrichment analyses of 55 preserved prostate cancer associated modules and preservation summary of corresponding GO_BP terms. (DOCX 47 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12864_2014_6720_MOESM2_ESM.docx"><caption><p>Additional file 2: Table S2.: Summarization of modules M1&#8201;~&#8201;M5. (DOCX 260 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12864_2014_6720_MOESM3_ESM.docx"><caption><p>Additional file 3: Table S3.: Enrichment analyses of 12 preserved prostate cancer-associated modules by K-means algorithm. (DOCX 27 KB)</p></caption></media></supplementary-material></sec></sec></body><back><fn-group><fn><p><bold>Competing interest</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#8217; contributions</bold></p><p>BS, ZZ, and PJ conceived and designed the experiments. JJ and PJ performed the experiments. JJ and PJ analyzed the data. JJ, PJ, ZZ, and BS wrote the paper. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was partially supported by National Institutes of Health grants (R01LM011177, P50CA095103, P50CA098131, and P30CA068485) and Ingram Professorship Funds (to ZZ). We gratefully acknowledge financial support from National Natural Science Foundation of China grants (31470821, 91230117, and 31170795) and the program of China Scholarship Council (No. 201206920018).</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baade</surname><given-names>PD</given-names></name><name><surname>Youlden</surname><given-names>DR</given-names></name><name><surname>Krnjacki</surname><given-names>LJ</given-names></name></person-group><article-title>International epidemiology of prostate cancer: geographical distribution and secular trends</article-title><source>Mol Nutr Food Res</source><year>2009</year><volume>53</volume><issue>2</issue><fpage>171</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200700511</pub-id><?supplied-pmid 19101947?><pub-id pub-id-type="pmid">19101947</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Brawley</surname><given-names>O</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths</article-title><source>CA Cancer J Clin</source><year>2011</year><volume>61</volume><issue>4</issue><fpage>212</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.3322/caac.20121</pub-id><?supplied-pmid 21685461?><pub-id pub-id-type="pmid">21685461</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gann</surname><given-names>PH</given-names></name></person-group><article-title>Risk factors for prostate cancer</article-title><source>Rev Urol</source><year>2002</year><volume>4</volume><issue>Suppl 5</issue><fpage>S3</fpage><lpage>S10</lpage><?supplied-pmid 16986064?><pub-id pub-id-type="pmid">16986064</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>WG</given-names></name><name><surname>De Marzo</surname><given-names>AM</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name></person-group><article-title>Prostate cancer</article-title><source>N Engl J Med</source><year>2003</year><volume>349</volume><issue>4</issue><fpage>366</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1056/NEJMra021562</pub-id><?supplied-pmid 12878745?><pub-id pub-id-type="pmid">12878745</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing Era</article-title><source>Biomed Res Int</source><year>2013</year><volume>2013</volume><fpage>6589252</fpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Holm</surname><given-names>NV</given-names></name><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Iliadou</surname><given-names>A</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Skytthe</surname><given-names>A</given-names></name><name><surname>Hemminki</surname><given-names>K</given-names></name></person-group><article-title>Environmental and heritable factors in the causation of cancer&#8211;analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><issue>2</issue><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1056/NEJM200007133430201</pub-id><?supplied-pmid 10891514?><pub-id pub-id-type="pmid">10891514</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>WF</given-names></name><name><surname>Braun</surname><given-names>MM</given-names></name><name><surname>Partin</surname><given-names>AW</given-names></name><name><surname>Caporaso</surname><given-names>N</given-names></name><name><surname>Walsh</surname><given-names>P</given-names></name></person-group><article-title>Heredity and prostate cancer: a study of World War II veteran twins</article-title><source>Prostate</source><year>1997</year><volume>33</volume><issue>4</issue><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0045(19971201)33:4&lt;240::AID-PROS3&gt;3.0.CO;2-L</pub-id><?supplied-pmid 9397195?><pub-id pub-id-type="pmid">9397195</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sawyers</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Rahmatpanah</surname><given-names>F</given-names></name><name><surname>Xia</surname><given-names>XQ</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Pio</surname><given-names>R</given-names></name><name><surname>Turan</surname><given-names>T</given-names></name><name><surname>Koziol</surname><given-names>JA</given-names></name><name><surname>Goodison</surname><given-names>S</given-names></name><name><surname>Carpenter</surname><given-names>P</given-names></name><name><surname>Wang-Rodriguez</surname><given-names>J</given-names></name><name><surname>Simoneau</surname><given-names>A</given-names></name><name><surname>Meyskens</surname><given-names>F</given-names></name><name><surname>Sutton</surname><given-names>M</given-names></name><name><surname>Lernhardt</surname><given-names>W</given-names></name><name><surname>Beach</surname><given-names>T</given-names></name><name><surname>Monforte</surname><given-names>J</given-names></name><name><surname>McClelland</surname><given-names>M</given-names></name><name><surname>Mercola</surname><given-names>D</given-names></name></person-group><article-title>Diagnosis of prostate cancer using differentially expressed genes in stroma</article-title><source>Cancer Res</source><year>2011</year><volume>71</volume><issue>7</issue><fpage>2476</fpage><lpage>2487</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-2585</pub-id><?supplied-pmid 21459804?><pub-id pub-id-type="pmid">21459804</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Vongsangnak</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression</article-title><source>BMC Med Genet</source><year>2014</year><volume>7</volume><issue>Suppl 1</issue><fpage>S3</fpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>TA</given-names></name><name><surname>Prueitt</surname><given-names>RL</given-names></name><name><surname>Yi</surname><given-names>M</given-names></name><name><surname>Howe</surname><given-names>TM</given-names></name><name><surname>Gillespie</surname><given-names>JW</given-names></name><name><surname>Yfantis</surname><given-names>HG</given-names></name><name><surname>Stephens</surname><given-names>RM</given-names></name><name><surname>Caporaso</surname><given-names>NE</given-names></name><name><surname>Loffredo</surname><given-names>CA</given-names></name><name><surname>Ambs</surname><given-names>S</given-names></name></person-group><article-title>Tumor immunobiological differences in prostate cancer between African-American and European-American men</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><issue>3</issue><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2608</pub-id><?supplied-pmid 18245496?><pub-id pub-id-type="pmid">18245496</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Jing</surname><given-names>Q</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Identifying novel prostate cancer associated pathways based on integrative microarray data analysis</article-title><source>Comput Biol Chem</source><year>2011</year><volume>35</volume><issue>3</issue><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2011.04.003</pub-id><?supplied-pmid 21704261?><pub-id pub-id-type="pmid">21704261</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name></person-group><article-title>Molecular signature of cancer at gene level or pathway level? case studies of colorectal cancer and prostate cancer microarray data</article-title><source>Comput Math Methods Med</source><year>2013</year><volume>2013</volume><fpage>909525</fpage><?supplied-pmid 23401724?><pub-id pub-id-type="pmid">23401724</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grisanzio</surname><given-names>C</given-names></name><name><surname>Werner</surname><given-names>L</given-names></name><name><surname>Takeda</surname><given-names>D</given-names></name><name><surname>Awoyemi</surname><given-names>BC</given-names></name><name><surname>Pomerantz</surname><given-names>MM</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Sooriakumaran</surname><given-names>P</given-names></name><name><surname>Robinson</surname><given-names>BD</given-names></name><name><surname>Leung</surname><given-names>R</given-names></name><name><surname>Schinzel</surname><given-names>AC</given-names></name><name><surname>Mills</surname><given-names>I</given-names></name><name><surname>Ross-Adams</surname><given-names>H</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Kido</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Petrozziello</surname><given-names>G</given-names></name><name><surname>Stack</surname><given-names>EC</given-names></name><name><surname>Lis</surname><given-names>R</given-names></name><name><surname>Kantoff</surname><given-names>PW</given-names></name><name><surname>Loda</surname><given-names>M</given-names></name><name><surname>Sartor</surname><given-names>O</given-names></name><name><surname>Egawa</surname><given-names>S</given-names></name><name><surname>Tewari</surname><given-names>AK</given-names></name><name><surname>Hahn</surname><given-names>WC</given-names></name><name><surname>Freedman</surname><given-names>ML</given-names></name></person-group><article-title>Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><issue>28</issue><fpage>11252</fpage><lpage>11257</lpage><pub-id pub-id-type="doi">10.1073/pnas.1200853109</pub-id><?supplied-pmid 22730461?><pub-id pub-id-type="pmid">22730461</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zang</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer</article-title><source>J Transl Med</source><year>2014</year><volume>12</volume><fpage>66</fpage><pub-id pub-id-type="doi">10.1186/1479-5876-12-66</pub-id><?supplied-pmid 24618011?><pub-id pub-id-type="pmid">24618011</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Top associated SNPs in prostate cancer are significantly enriched in cis-expression quantitative trait loci and at transcription factor binding sites</article-title><source>Oncotarget</source><year>2014</year><volume>5</volume><issue>15</issue><fpage>6168</fpage><lpage>6177</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.2179</pub-id><?supplied-pmid 25026280?><pub-id pub-id-type="pmid">25026280</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Wiklund</surname><given-names>F</given-names></name><name><surname>Wiley</surname><given-names>K</given-names></name><name><surname>Isaacs</surname><given-names>SD</given-names></name><name><surname>Stattin</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Duggan</surname><given-names>D</given-names></name><name><surname>Carpten</surname><given-names>JD</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name><name><surname>Gronberg</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>SL</given-names></name><name><surname>Chang</surname><given-names>BL</given-names></name></person-group><article-title>Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><issue>6</issue><fpage>2176</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3151</pub-id><?supplied-pmid 19258504?><pub-id pub-id-type="pmid">19258504</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LC</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Shiina</surname><given-names>H</given-names></name><name><surname>Kane</surname><given-names>CJ</given-names></name><name><surname>Dahiya</surname><given-names>R</given-names></name></person-group><article-title>PGDB: a curated and integrated database of genes related to the prostate</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><issue>1</issue><fpage>291</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg008</pub-id><?supplied-pmid 12520005?><pub-id pub-id-type="pmid">12520005</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Hei</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name></person-group><article-title>Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>3231</fpage><?supplied-pmid 24488081?><pub-id pub-id-type="pmid">24488081</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Kaipia</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer</article-title><source>BMC Syst Biol</source><year>2013</year><volume>7</volume><issue>Suppl 3</issue><fpage>S6</fpage><pub-id pub-id-type="doi">10.1186/1752-0509-7-S3-S6</pub-id><?supplied-pmid 24555436?><pub-id pub-id-type="pmid">24555436</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>BJ</given-names></name><name><surname>Feldman</surname><given-names>D</given-names></name></person-group><article-title>The development of androgen-independent prostate cancer</article-title><source>Nat Rev Cancer</source><year>2001</year><volume>1</volume><issue>1</issue><fpage>34</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/35094009</pub-id><?supplied-pmid 11900250?><pub-id pub-id-type="pmid">11900250</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Grennan</surname><given-names>K</given-names></name><name><surname>Pibiri</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Badner</surname><given-names>JA</given-names></name><name><surname>Gershon</surname><given-names>ES</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name></person-group><article-title>Two gene co-expression modules differentiate psychotics and controls</article-title><source>Mol Psychiatry</source><year>2012</year><volume>18</volume><issue>12</issue><fpage>1308</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/mp.2012.146</pub-id><?supplied-pmid 23147385?><pub-id pub-id-type="pmid">23147385</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name></person-group><article-title>The genomics of gene expression</article-title><source>Genomics</source><year>2004</year><volume>84</volume><issue>3</issue><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2004.05.002</pub-id><?supplied-pmid 15498452?><pub-id pub-id-type="pmid">15498452</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barabasi</surname><given-names>AL</given-names></name><name><surname>Gulbahce</surname><given-names>N</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name></person-group><article-title>Network medicine: a network-based approach to human disease</article-title><source>Nat Rev Genet</source><year>2011</year><volume>12</volume><issue>1</issue><fpage>56</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nrg2918</pub-id><?supplied-pmid 21164525?><pub-id pub-id-type="pmid">21164525</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>DR</given-names></name><name><surname>Barrette</surname><given-names>TR</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Chinnaiyan</surname><given-names>AM</given-names></name></person-group><article-title>Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><issue>15</issue><fpage>4427</fpage><lpage>4433</lpage><?supplied-pmid 12154050?><pub-id pub-id-type="pmid">12154050</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Koller</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><article-title>A gene-coexpression network for global discovery of conserved genetic modules</article-title><source>Science</source><year>2003</year><volume>302</volume><issue>5643</issue><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1126/science.1087447</pub-id><?supplied-pmid 12934013?><pub-id pub-id-type="pmid">12934013</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>A general framework for weighted gene co-expression network analysis</article-title><source>Stat Appl Genet Mol Biol</source><year>2005</year><volume>4</volume><fpage>Article17</fpage><?supplied-pmid 16646834?><pub-id pub-id-type="pmid">16646834</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-David</surname><given-names>E</given-names></name><name><surname>Shifman</surname><given-names>S</given-names></name></person-group><article-title>Networks of neuronal genes affected by common and rare variants in autism spectrum disorders</article-title><source>PLoS Genet</source><year>2012</year><volume>8</volume><issue>3</issue><fpage>e1002556</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1002556</pub-id><?supplied-pmid 22412387?><pub-id pub-id-type="pmid">22412387</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><year>2008</year><volume>9</volume><fpage>559</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><?supplied-pmid 19114008?><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Oldham</surname><given-names>MC</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>Is my network module preserved and reproducible?</article-title><source>PLoS Comput Biol</source><year>2011</year><volume>7</volume><issue>1</issue><fpage>e1001057</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001057</pub-id><?supplied-pmid 21283776?><pub-id pub-id-type="pmid">21283776</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldham</surname><given-names>MC</given-names></name><name><surname>Konopka</surname><given-names>G</given-names></name><name><surname>Iwamoto</surname><given-names>K</given-names></name><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Functional organization of the transcriptome in human brain</article-title><source>Nat Neurosci</source><year>2008</year><volume>11</volume><issue>11</issue><fpage>1271</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1038/nn.2207</pub-id><?supplied-pmid 18849986?><pub-id pub-id-type="pmid">18849986</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>28</issue><fpage>12698</fpage><lpage>12703</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914257107</pub-id><?supplied-pmid 20616000?><pub-id pub-id-type="pmid">20616000</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Harris</surname><given-names>MA</given-names></name><name><surname>Hill</surname><given-names>DP</given-names></name><name><surname>Issel-Tarver</surname><given-names>L</given-names></name><name><surname>Kasarskis</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>Matese</surname><given-names>JC</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name><name><surname>Ringwald</surname><given-names>M</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name></person-group><article-title>Gene ontology: tool for the unification of biology. The gene ontology consortium</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><issue>1</issue><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id><?supplied-pmid 10802651?><pub-id pub-id-type="pmid">10802651</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>XQ</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Sawyers</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Wang-Rodriquez</surname><given-names>J</given-names></name><name><surname>Mercola</surname><given-names>D</given-names></name><name><surname>McClelland</surname><given-names>M</given-names></name></person-group><article-title>In silico estimates of tissue components in surgical samples based on expression profiling data</article-title><source>Cancer Res</source><year>2010</year><volume>70</volume><issue>16</issue><fpage>6448</fpage><lpage>6455</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-0021</pub-id><?supplied-pmid 20663908?><pub-id pub-id-type="pmid">20663908</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Johnston</surname><given-names>P</given-names></name><name><surname>Lowe</surname><given-names>JK</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Blencowe</surname><given-names>BJ</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title><source>Nature</source><year>2011</year><volume>474</volume><issue>7351</issue><fpage>380</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1038/nature10110</pub-id><?supplied-pmid 21614001?><pub-id pub-id-type="pmid">21614001</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Bolstad</surname><given-names>BM</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name><name><surname>Cope</surname><given-names>LM</given-names></name><name><surname>Hobbs</surname><given-names>B</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group><article-title>Summaries of Affymetrix GeneChip probe level data</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><issue>4</issue><fpage>e15</fpage><pub-id pub-id-type="doi">10.1093/nar/gng015</pub-id><?supplied-pmid 12582260?><pub-id pub-id-type="pmid">12582260</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MP</given-names></name><name><surname>Grundy</surname><given-names>WN</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Cristianini</surname><given-names>N</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Ares</surname><given-names>M</given-names><suffix>Jr</suffix></name><name><surname>Haussler</surname><given-names>D</given-names></name></person-group><article-title>Knowledge-based analysis of microarray gene expression data by using support vector machines</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><volume>97</volume><issue>1</issue><fpage>262</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.1.262</pub-id><?supplied-pmid 10618406?><pub-id pub-id-type="pmid">10618406</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>43</issue><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><?supplied-pmid 16199517?><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R</article-title><source>Bioinformatics</source><year>2008</year><volume>24</volume><issue>5</issue><fpage>719</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm563</pub-id><?supplied-pmid 18024473?><pub-id pub-id-type="pmid">18024473</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>Eigengene networks for studying the relationships between co-expression modules</article-title><source>BMC Syst Biol</source><year>2007</year><volume>1</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1186/1752-0509-1-54</pub-id><?supplied-pmid 18031580?><pub-id pub-id-type="pmid">18031580</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storey</surname><given-names>JD</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><article-title>Statistical significance for genomewide studies</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><issue>16</issue><fpage>9440</fpage><lpage>9445</lpage><pub-id pub-id-type="doi">10.1073/pnas.1530509100</pub-id><?supplied-pmid 12883005?><pub-id pub-id-type="pmid">12883005</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spielman</surname><given-names>RS</given-names></name><name><surname>Bastone</surname><given-names>LA</given-names></name><name><surname>Burdick</surname><given-names>JT</given-names></name><name><surname>Morley</surname><given-names>M</given-names></name><name><surname>Ewens</surname><given-names>WJ</given-names></name><name><surname>Cheung</surname><given-names>VG</given-names></name></person-group><article-title>Common genetic variants account for differences in gene expression among ethnic groups</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><issue>2</issue><fpage>226</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1038/ng1955</pub-id><?supplied-pmid 17206142?><pub-id pub-id-type="pmid">17206142</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stranger</surname><given-names>BE</given-names></name><name><surname>Forrest</surname><given-names>MS</given-names></name><name><surname>Dunning</surname><given-names>M</given-names></name><name><surname>Ingle</surname><given-names>CE</given-names></name><name><surname>Beazley</surname><given-names>C</given-names></name><name><surname>Thorne</surname><given-names>N</given-names></name><name><surname>Redon</surname><given-names>R</given-names></name><name><surname>Bird</surname><given-names>CP</given-names></name><name><surname>de Grassi</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Tyler-Smith</surname><given-names>C</given-names></name><name><surname>Carter</surname><given-names>N</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name><name><surname>Tavare</surname><given-names>S</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Hurles</surname><given-names>ME</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name></person-group><article-title>Relative impact of nucleotide and copy number variation on gene expression phenotypes</article-title><source>Science</source><year>2007</year><volume>315</volume><issue>5813</issue><fpage>848</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1126/science.1136678</pub-id><?supplied-pmid 17289997?><pub-id pub-id-type="pmid">17289997</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy</surname><given-names>E</given-names></name><name><surname>Yelensky</surname><given-names>R</given-names></name><name><surname>Bonakdar</surname><given-names>S</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Shaw</surname><given-names>SY</given-names></name><name><surname>Wolfish</surname><given-names>CS</given-names></name><name><surname>Slavik</surname><given-names>JM</given-names></name><name><surname>Cotsapas</surname><given-names>C</given-names></name><name><surname>Rivas</surname><given-names>M</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Cahir-McFarland</surname><given-names>E</given-names></name><name><surname>Kieff</surname><given-names>E</given-names></name><name><surname>Hafler</surname><given-names>D</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name></person-group><article-title>Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines</article-title><source>PLoS Genet</source><year>2008</year><volume>4</volume><issue>11</issue><fpage>e1000287</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000287</pub-id><?supplied-pmid 19043577?><pub-id pub-id-type="pmid">19043577</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Hancks</surname><given-names>DC</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name><name><surname>Cheung</surname><given-names>VG</given-names></name><name><surname>Spielman</surname><given-names>RS</given-names></name></person-group><article-title>Effects of cis and trans genetic ancestry on gene expression in African Americans</article-title><source>PLoS Genet</source><year>2008</year><volume>4</volume><issue>12</issue><fpage>e1000294</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000294</pub-id><?supplied-pmid 19057673?><pub-id pub-id-type="pmid">19057673</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimas</surname><given-names>AS</given-names></name><name><surname>Deutsch</surname><given-names>S</given-names></name><name><surname>Stranger</surname><given-names>BE</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Borel</surname><given-names>C</given-names></name><name><surname>Attar-Cohen</surname><given-names>H</given-names></name><name><surname>Ingle</surname><given-names>C</given-names></name><name><surname>Beazley</surname><given-names>C</given-names></name><name><surname>Gutierrez Arcelus</surname><given-names>M</given-names></name><name><surname>Sekowska</surname><given-names>M</given-names></name><name><surname>Gagnebin</surname><given-names>M</given-names></name><name><surname>Nisbett</surname><given-names>J</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name></person-group><article-title>Common regulatory variation impacts gene expression in a cell type-dependent manner</article-title><source>Science</source><year>2009</year><volume>325</volume><issue>5945</issue><fpage>1246</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1126/science.1174148</pub-id><?supplied-pmid 19644074?><pub-id pub-id-type="pmid">19644074</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>SB</given-names></name><name><surname>Sammeth</surname><given-names>M</given-names></name><name><surname>Gutierrez-Arcelus</surname><given-names>M</given-names></name><name><surname>Lach</surname><given-names>RP</given-names></name><name><surname>Ingle</surname><given-names>C</given-names></name><name><surname>Nisbett</surname><given-names>J</given-names></name><name><surname>Guigo</surname><given-names>R</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name></person-group><article-title>Transcriptome genetics using second generation sequencing in a Caucasian population</article-title><source>Nature</source><year>2010</year><volume>464</volume><issue>7289</issue><fpage>773</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1038/nature08903</pub-id><?supplied-pmid 20220756?><pub-id pub-id-type="pmid">20220756</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickrell</surname><given-names>JK</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Pai</surname><given-names>AA</given-names></name><name><surname>Degner</surname><given-names>JF</given-names></name><name><surname>Engelhardt</surname><given-names>BE</given-names></name><name><surname>Nkadori</surname><given-names>E</given-names></name><name><surname>Veyrieras</surname><given-names>JB</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Gilad</surname><given-names>Y</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name></person-group><article-title>Understanding mechanisms underlying human gene expression variation with RNA sequencing</article-title><source>Nature</source><year>2010</year><volume>464</volume><issue>7289</issue><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1038/nature08872</pub-id><?supplied-pmid 20220758?><pub-id pub-id-type="pmid">20220758</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Dogrusoz</surname><given-names>U</given-names></name><name><surname>Gross</surname><given-names>BE</given-names></name><name><surname>Sumer</surname><given-names>SO</given-names></name><name><surname>Aksoy</surname><given-names>BA</given-names></name><name><surname>Jacobsen</surname><given-names>A</given-names></name><name><surname>Byrne</surname><given-names>CJ</given-names></name><name><surname>Heuer</surname><given-names>ML</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Antipin</surname><given-names>Y</given-names></name><name><surname>Reva</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>AP</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name></person-group><article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title><source>Cancer Discov</source><year>2012</year><volume>2</volume><issue>5</issue><fpage>401</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id><?supplied-pmid 22588877?><pub-id pub-id-type="pmid">22588877</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mermel</surname><given-names>CH</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Hill</surname><given-names>B</given-names></name><name><surname>Meyerson</surname><given-names>ML</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name></person-group><article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title><source>Genome Biol</source><year>2011</year><volume>12</volume><issue>4</issue><fpage>R41</fpage><pub-id pub-id-type="doi">10.1186/gb-2011-12-4-r41</pub-id><?supplied-pmid 21527027?><pub-id pub-id-type="pmid">21527027</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Kirov</surname><given-names>S</given-names></name><name><surname>Snoddy</surname><given-names>J</given-names></name></person-group><article-title>WebGestalt: an integrated system for exploring gene sets in various biological contexts</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><issue>Web Server issue</issue><fpage>W741</fpage><lpage>W748</lpage><pub-id pub-id-type="doi">10.1093/nar/gki475</pub-id><?supplied-pmid 15980575?><pub-id pub-id-type="pmid">15980575</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iakoucheva</surname><given-names>LM</given-names></name><name><surname>Brown</surname><given-names>CJ</given-names></name><name><surname>Lawson</surname><given-names>JD</given-names></name><name><surname>Obradovic</surname><given-names>Z</given-names></name><name><surname>Dunker</surname><given-names>AK</given-names></name></person-group><article-title>Intrinsic disorder in cell-signaling and cancer-associated proteins</article-title><source>J Mol Biol</source><year>2002</year><volume>323</volume><issue>3</issue><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(02)00969-5</pub-id><?supplied-pmid 12381310?><pub-id pub-id-type="pmid">12381310</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>R</given-names></name></person-group><article-title>Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents</article-title><source>Biochem Pharmacol</source><year>2000</year><volume>60</volume><issue>8</issue><fpage>1051</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(00)00385-3</pub-id><?supplied-pmid 11007941?><pub-id pub-id-type="pmid">11007941</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArdle</surname><given-names>PA</given-names></name><name><surname>Mir</surname><given-names>K</given-names></name><name><surname>Almushatat</surname><given-names>AS</given-names></name><name><surname>Wallace</surname><given-names>AM</given-names></name><name><surname>Underwood</surname><given-names>MA</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name></person-group><article-title>Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer</article-title><source>Urol Int</source><year>2006</year><volume>77</volume><issue>2</issue><fpage>127</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1159/000093905</pub-id><?supplied-pmid 16888416?><pub-id pub-id-type="pmid">16888416</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benhar</surname><given-names>M</given-names></name><name><surname>Engelberg</surname><given-names>D</given-names></name><name><surname>Levitzki</surname><given-names>A</given-names></name></person-group><article-title>ROS, stress-activated kinases and stress signaling in cancer</article-title><source>EMBO Rep</source><year>2002</year><volume>3</volume><issue>5</issue><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1093/embo-reports/kvf094</pub-id><?supplied-pmid 11991946?><pub-id pub-id-type="pmid">11991946</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>AM</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><article-title>Post-translational modification of p53 in tumorigenesis</article-title><source>Nat Rev Cancer</source><year>2004</year><volume>4</volume><issue>10</issue><fpage>793</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1038/nrc1455</pub-id><?supplied-pmid 15510160?><pub-id pub-id-type="pmid">15510160</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Visser</surname><given-names>KE</given-names></name><name><surname>Eichten</surname><given-names>A</given-names></name><name><surname>Coussens</surname><given-names>LM</given-names></name></person-group><article-title>Paradoxical roles of the immune system during cancer development</article-title><source>Nat Rev Cancer</source><year>2006</year><volume>6</volume><issue>1</issue><fpage>24</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/nrc1782</pub-id><?supplied-pmid 16397525?><pub-id pub-id-type="pmid">16397525</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>S</given-names></name><name><surname>Chintapalli</surname><given-names>J</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name></person-group><article-title>Taxol induces bcl-2 phosphorylation and death of prostate cancer cells</article-title><source>Cancer Res</source><year>1996</year><volume>56</volume><issue>6</issue><fpage>1253</fpage><lpage>1255</lpage><?supplied-pmid 8640809?><pub-id pub-id-type="pmid">8640809</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurumurthy</surname><given-names>S</given-names></name><name><surname>Vasudevan</surname><given-names>KM</given-names></name><name><surname>Rangnekar</surname><given-names>VM</given-names></name></person-group><article-title>Regulation of apoptosis in prostate cancer</article-title><source>Cancer Metastasis Rev</source><year>2001</year><volume>20</volume><issue>3&#8211;4</issue><fpage>225</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1023/A:1015583310759</pub-id><?supplied-pmid 12085964?><pub-id pub-id-type="pmid">12085964</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenschein</surname><given-names>C</given-names></name><name><surname>Olea</surname><given-names>N</given-names></name><name><surname>Pasanen</surname><given-names>ME</given-names></name><name><surname>Soto</surname><given-names>AM</given-names></name></person-group><article-title>Negative controls of cell proliferation: human prostate cancer cells and androgens</article-title><source>Cancer Res</source><year>1989</year><volume>49</volume><issue>13</issue><fpage>3474</fpage><lpage>3481</lpage><?supplied-pmid 2731169?><pub-id pub-id-type="pmid">2731169</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>TD</given-names></name><name><surname>Yu</surname><given-names>JJ</given-names></name><name><surname>Spiotto</surname><given-names>MT</given-names></name><name><surname>Bartkowski</surname><given-names>M</given-names></name><name><surname>Simons</surname><given-names>JW</given-names></name></person-group><article-title>Characterization of the role of IL-6 in the progression of prostate cancer</article-title><source>Prostate</source><year>1999</year><volume>38</volume><issue>3</issue><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0045(19990215)38:3&lt;199::AID-PROS4&gt;3.0.CO;2-H</pub-id><?supplied-pmid 10068344?><pub-id pub-id-type="pmid">10068344</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierconti</surname><given-names>F</given-names></name><name><surname>Martini</surname><given-names>M</given-names></name><name><surname>Pinto</surname><given-names>F</given-names></name><name><surname>Cenci</surname><given-names>T</given-names></name><name><surname>Capodimonti</surname><given-names>S</given-names></name><name><surname>Calarco</surname><given-names>A</given-names></name><name><surname>Bassi</surname><given-names>PF</given-names></name><name><surname>Larocca</surname><given-names>LM</given-names></name></person-group><article-title>Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior</article-title><source>Prostate</source><year>2011</year><volume>71</volume><issue>3</issue><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/pros.21245</pub-id><?supplied-pmid 20717995?><pub-id pub-id-type="pmid">20717995</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>K</given-names></name><name><surname>Gopisetty</surname><given-names>G</given-names></name><name><surname>Gordian</surname><given-names>E</given-names></name><name><surname>Navarro</surname><given-names>L</given-names></name><name><surname>Hader</surname><given-names>C</given-names></name><name><surname>Reis</surname><given-names>IM</given-names></name><name><surname>Schulz</surname><given-names>WA</given-names></name><name><surname>Singal</surname><given-names>R</given-names></name></person-group><article-title>Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><issue>4</issue><fpage>1527</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3609</pub-id><?supplied-pmid 19190346?><pub-id pub-id-type="pmid">19190346</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name><name><surname>Donald</surname><given-names>C</given-names></name><name><surname>Lilly</surname><given-names>MB</given-names></name><name><surname>Kraft</surname><given-names>AS</given-names></name></person-group><article-title>Pim family kinases enhance tumor growth of prostate cancer cells</article-title><source>Mol Cancer Res</source><year>2005</year><volume>3</volume><issue>8</issue><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-05-0007</pub-id><?supplied-pmid 16123140?><pub-id pub-id-type="pmid">16123140</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud</surname><given-names>DS</given-names></name><name><surname>Daugherty</surname><given-names>SE</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Platz</surname><given-names>EA</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><name><surname>Crawford</surname><given-names>ED</given-names></name><name><surname>Hsing</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>WY</given-names></name><name><surname>Hayes</surname><given-names>RB</given-names></name></person-group><article-title>Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><issue>8</issue><fpage>4525</fpage><lpage>4530</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3987</pub-id><?supplied-pmid 16618781?><pub-id pub-id-type="pmid">16618781</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kibel</surname><given-names>AS</given-names></name><name><surname>Suarez</surname><given-names>BK</given-names></name><name><surname>Belani</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Webster</surname><given-names>R</given-names></name><name><surname>Brophy-Ebbers</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Catalona</surname><given-names>WJ</given-names></name><name><surname>Picus</surname><given-names>J</given-names></name><name><surname>Goodfellow</surname><given-names>PJ</given-names></name></person-group><article-title>CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><issue>9</issue><fpage>2033</fpage><lpage>2036</lpage><?supplied-pmid 12727815?><pub-id pub-id-type="pmid">12727815</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loberg</surname><given-names>RD</given-names></name><name><surname>Day</surname><given-names>LL</given-names></name><name><surname>Harwood</surname><given-names>J</given-names></name><name><surname>Ying</surname><given-names>C</given-names></name><name><surname>St John</surname><given-names>LN</given-names></name><name><surname>Giles</surname><given-names>R</given-names></name><name><surname>Neeley</surname><given-names>CK</given-names></name><name><surname>Pienta</surname><given-names>KJ</given-names></name></person-group><article-title>CCL2 is a potent regulator of prostate cancer cell migration and proliferation</article-title><source>Neoplasia</source><year>2006</year><volume>8</volume><issue>7</issue><fpage>578</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1593/neo.06280</pub-id><?supplied-pmid 16867220?><pub-id pub-id-type="pmid">16867220</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushima-Miyagi</surname><given-names>T</given-names></name><name><surname>Hatano</surname><given-names>K</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Li-Wen</surname><given-names>L</given-names></name><name><surname>Nishikawa</surname><given-names>T</given-names></name><name><surname>Saga</surname><given-names>K</given-names></name><name><surname>Shimbo</surname><given-names>T</given-names></name><name><surname>Kaneda</surname><given-names>Y</given-names></name></person-group><article-title>TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles</article-title><source>Clin Cancer Res</source><year>2012</year><volume>18</volume><issue>22</issue><fpage>6271</fpage><lpage>6283</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-1595</pub-id><?supplied-pmid 23014529?><pub-id pub-id-type="pmid">23014529</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prendergast</surname><given-names>GC</given-names></name></person-group><article-title>Actin&#8217; up: RhoB in cancer and apoptosis</article-title><source>Nat Rev Cancer</source><year>2001</year><volume>1</volume><issue>2</issue><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1038/35101096</pub-id><?supplied-pmid 11905808?><pub-id pub-id-type="pmid">11905808</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battista</surname><given-names>MC</given-names></name><name><surname>Guimond</surname><given-names>MO</given-names></name><name><surname>Roberge</surname><given-names>C</given-names></name><name><surname>Doueik</surname><given-names>AA</given-names></name><name><surname>Fazli</surname><given-names>L</given-names></name><name><surname>Gleave</surname><given-names>M</given-names></name><name><surname>Sabbagh</surname><given-names>R</given-names></name><name><surname>Gallo-Payet</surname><given-names>N</given-names></name></person-group><article-title>Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer</article-title><source>Prostate</source><year>2010</year><volume>70</volume><issue>9</issue><fpage>921</fpage><lpage>933</lpage><?supplied-pmid 20166102?><pub-id pub-id-type="pmid">20166102</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Nie</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><article-title>MicroRNA145 targets BNIP3 and suppresses prostate cancer progression</article-title><source>Cancer Res</source><year>2010</year><volume>70</volume><issue>7</issue><fpage>2728</fpage><lpage>2738</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3718</pub-id><?supplied-pmid 20332243?><pub-id pub-id-type="pmid">20332243</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochester</surname><given-names>MA</given-names></name><name><surname>Riedemann</surname><given-names>J</given-names></name><name><surname>Hellawell</surname><given-names>GO</given-names></name><name><surname>Brewster</surname><given-names>SF</given-names></name><name><surname>Macaulay</surname><given-names>VM</given-names></name></person-group><article-title>Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer</article-title><source>Cancer Gene Ther</source><year>2005</year><volume>12</volume><issue>1</issue><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/sj.cgt.7700775</pub-id><?supplied-pmid 15499378?><pub-id pub-id-type="pmid">15499378</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalava</surname><given-names>SE</given-names></name><name><surname>Urbanucci</surname><given-names>A</given-names></name><name><surname>Latonen</surname><given-names>L</given-names></name><name><surname>Waltering</surname><given-names>KK</given-names></name><name><surname>Sahu</surname><given-names>B</given-names></name><name><surname>Janne</surname><given-names>OA</given-names></name><name><surname>Seppala</surname><given-names>J</given-names></name><name><surname>Lahdesmaki</surname><given-names>H</given-names></name><name><surname>Tammela</surname><given-names>TL</given-names></name><name><surname>Visakorpi</surname><given-names>T</given-names></name></person-group><article-title>Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer</article-title><source>Oncogene</source><year>2012</year><volume>31</volume><issue>41</issue><fpage>4460</fpage><lpage>4471</lpage><pub-id pub-id-type="doi">10.1038/onc.2011.624</pub-id><?supplied-pmid 22266859?><pub-id pub-id-type="pmid">22266859</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>ML</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Swanson</surname><given-names>PE</given-names></name><name><surname>Humphrey</surname><given-names>PA</given-names></name></person-group><article-title>Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells</article-title><source>Cell Growth Differ</source><year>1994</year><volume>5</volume><issue>7</issue><fpage>735</fpage><lpage>741</lpage><?supplied-pmid 7947388?><pub-id pub-id-type="pmid">7947388</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taichman</surname><given-names>RS</given-names></name><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>ET</given-names></name><name><surname>Pienta</surname><given-names>KJ</given-names></name><name><surname>Taichman</surname><given-names>NS</given-names></name><name><surname>McCauley</surname><given-names>LK</given-names></name></person-group><article-title>Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><issue>6</issue><fpage>1832</fpage><lpage>1837</lpage><?supplied-pmid 11912162?><pub-id pub-id-type="pmid">11912162</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obinata</surname><given-names>D</given-names></name><name><surname>Takayama</surname><given-names>K</given-names></name><name><surname>Urano</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Horie-Inoue</surname><given-names>K</given-names></name><name><surname>Ouchi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name></person-group><article-title>ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration</article-title><source>Int J Cancer</source><year>2012</year><volume>130</volume><issue>10</issue><fpage>2240</fpage><lpage>2248</lpage><pub-id pub-id-type="doi">10.1002/ijc.26224</pub-id><?supplied-pmid 21647875?><pub-id pub-id-type="pmid">21647875</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>LX</given-names></name><name><surname>Li</surname><given-names>RT</given-names></name><name><surname>Zhang</surname><given-names>JB</given-names></name><name><surname>Zhong</surname><given-names>WZ</given-names></name><name><surname>Bai</surname><given-names>JL</given-names></name><name><surname>Liu</surname><given-names>BR</given-names></name><name><surname>Zheng</surname><given-names>MH</given-names></name><name><surname>Qian</surname><given-names>XP</given-names></name></person-group><article-title>The E-cadherin (CDH1)&#8211;160 C/A polymorphism and prostate cancer risk: a meta-analysis</article-title><source>Eur J Hum Genet</source><year>2009</year><volume>17</volume><issue>2</issue><fpage>244</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2008.157</pub-id><?supplied-pmid 18781193?><pub-id pub-id-type="pmid">18781193</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Revelo</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><article-title>Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice</article-title><source>Clin Cancer Res</source><year>2007</year><volume>13</volume><issue>19</issue><fpage>5692</fpage><lpage>5702</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-1078</pub-id><?supplied-pmid 17908958?><pub-id pub-id-type="pmid">17908958</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochownik</surname><given-names>EV</given-names></name><name><surname>Eagle Grove</surname><given-names>L</given-names></name><name><surname>Deubler</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>XL</given-names></name><name><surname>Stephenson</surname><given-names>RA</given-names></name><name><surname>Rohr</surname><given-names>LR</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Brothman</surname><given-names>AR</given-names></name></person-group><article-title>Commonly occurring loss and mutation of the MXI1 gene in prostate cancer</article-title><source>Genes Chromosomes Cancer</source><year>1998</year><volume>22</volume><issue>4</issue><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199808)22:4&lt;295::AID-GCC5&gt;3.0.CO;2-Q</pub-id><?supplied-pmid 9669667?><pub-id pub-id-type="pmid">9669667</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehen&#8242;kyi</surname><given-names>V</given-names></name><name><surname>Flourakis</surname><given-names>M</given-names></name><name><surname>Skryma</surname><given-names>R</given-names></name><name><surname>Prevarskaya</surname><given-names>N</given-names></name></person-group><article-title>TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways</article-title><source>Oncogene</source><year>2007</year><volume>26</volume><issue>52</issue><fpage>7380</fpage><lpage>7385</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1210545</pub-id><?supplied-pmid 17533368?><pub-id pub-id-type="pmid">17533368</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sankpal</surname><given-names>UT</given-names></name><name><surname>Goodison</surname><given-names>S</given-names></name><name><surname>Abdelrahim</surname><given-names>M</given-names></name><name><surname>Basha</surname><given-names>R</given-names></name></person-group><article-title>Targeting Sp1 transcription factors in prostate cancer therapy</article-title><source>Med Chem</source><year>2011</year><volume>7</volume><issue>5</issue><fpage>518</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.2174/157340611796799203</pub-id><?supplied-pmid 22022994?><pub-id pub-id-type="pmid">22022994</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thebault</surname><given-names>S</given-names></name><name><surname>Flourakis</surname><given-names>M</given-names></name><name><surname>Vanoverberghe</surname><given-names>K</given-names></name><name><surname>Vandermoere</surname><given-names>F</given-names></name><name><surname>Roudbaraki</surname><given-names>M</given-names></name><name><surname>Lehen&#8217;kyi</surname><given-names>V</given-names></name><name><surname>Slomianny</surname><given-names>C</given-names></name><name><surname>Beck</surname><given-names>B</given-names></name><name><surname>Mariot</surname><given-names>P</given-names></name><name><surname>Bonnal</surname><given-names>JL</given-names></name><name><surname>Mauroy</surname><given-names>B</given-names></name><name><surname>Shuba</surname><given-names>Y</given-names></name><name><surname>Capiod</surname><given-names>T</given-names></name><name><surname>Skryma</surname><given-names>R</given-names></name><name><surname>Prevarskaya</surname><given-names>N</given-names></name></person-group><article-title>Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><issue>4</issue><fpage>2038</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0376</pub-id><?supplied-pmid 16489003?><pub-id pub-id-type="pmid">16489003</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moltzahn</surname><given-names>F</given-names></name><name><surname>Olshen</surname><given-names>AB</given-names></name><name><surname>Baehner</surname><given-names>L</given-names></name><name><surname>Peek</surname><given-names>A</given-names></name><name><surname>Fong</surname><given-names>L</given-names></name><name><surname>Stoppler</surname><given-names>H</given-names></name><name><surname>Simko</surname><given-names>J</given-names></name><name><surname>Hilton</surname><given-names>JF</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name><name><surname>Blelloch</surname><given-names>R</given-names></name></person-group><article-title>Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients</article-title><source>Cancer Res</source><year>2011</year><volume>71</volume><issue>2</issue><fpage>550</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1229</pub-id><?supplied-pmid 21098088?><pub-id pub-id-type="pmid">21098088</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonci</surname><given-names>D</given-names></name><name><surname>Coppola</surname><given-names>V</given-names></name><name><surname>Musumeci</surname><given-names>M</given-names></name><name><surname>Addario</surname><given-names>A</given-names></name><name><surname>Giuffrida</surname><given-names>R</given-names></name><name><surname>Memeo</surname><given-names>L</given-names></name><name><surname>D&#8217;Urso</surname><given-names>L</given-names></name><name><surname>Pagliuca</surname><given-names>A</given-names></name><name><surname>Biffoni</surname><given-names>M</given-names></name><name><surname>Labbaye</surname><given-names>C</given-names></name><name><surname>Bartucci</surname><given-names>M</given-names></name><name><surname>Muto</surname><given-names>G</given-names></name><name><surname>Peschle</surname><given-names>C</given-names></name><name><surname>De Maria</surname><given-names>R</given-names></name></person-group><article-title>The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities</article-title><source>Nat Med</source><year>2008</year><volume>14</volume><issue>11</issue><fpage>1271</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1038/nm.1880</pub-id><?supplied-pmid 18931683?><pub-id pub-id-type="pmid">18931683</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Sarkar</surname><given-names>FH</given-names></name></person-group><article-title>miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells</article-title><source>Stem Cells</source><year>2009</year><volume>27</volume><issue>8</issue><fpage>1712</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1002/stem.101</pub-id><?supplied-pmid 19544444?><pub-id pub-id-type="pmid">19544444</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>1</issue><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shyamsundar</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Montgomery</surname><given-names>K</given-names></name><name><surname>Jorden</surname><given-names>M</given-names></name><name><surname>Sethuraman</surname><given-names>A</given-names></name><name><surname>van de Rijn</surname><given-names>M</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name><name><surname>Pollack</surname><given-names>JR</given-names></name></person-group><article-title>A DNA microarray survey of gene expression in normal human tissues</article-title><source>Genome Biol</source><year>2005</year><volume>6</volume><issue>3</issue><fpage>R22</fpage><pub-id pub-id-type="doi">10.1186/gb-2005-6-3-r22</pub-id><?supplied-pmid 15774023?><pub-id pub-id-type="pmid">15774023</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaTulippe</surname><given-names>E</given-names></name><name><surname>Satagopan</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Scher</surname><given-names>H</given-names></name><name><surname>Scardino</surname><given-names>P</given-names></name><name><surname>Reuter</surname><given-names>V</given-names></name><name><surname>Gerald</surname><given-names>WL</given-names></name></person-group><article-title>Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><issue>15</issue><fpage>4499</fpage><lpage>4506</lpage><?supplied-pmid 12154061?><pub-id pub-id-type="pmid">12154061</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavazoie</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>JD</given-names></name><name><surname>Campbell</surname><given-names>MJ</given-names></name><name><surname>Cho</surname><given-names>RJ</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name></person-group><article-title>Systematic determination of genetic network architecture</article-title><source>Nat Genet</source><year>1999</year><volume>22</volume><issue>3</issue><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/10343</pub-id><?supplied-pmid 10391217?><pub-id pub-id-type="pmid">10391217</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Parsons</surname><given-names>DW</given-names></name><name><surname>Lin</surname><given-names>JC</given-names></name><name><surname>Leary</surname><given-names>RJ</given-names></name><name><surname>Angenendt</surname><given-names>P</given-names></name><name><surname>Mankoo</surname><given-names>P</given-names></name><name><surname>Carter</surname><given-names>H</given-names></name><name><surname>Kamiyama</surname><given-names>H</given-names></name><name><surname>Jimeno</surname><given-names>A</given-names></name><name><surname>Hong</surname><given-names>SM</given-names></name><name><surname>Fu</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>MT</given-names></name><name><surname>Calhoun</surname><given-names>ES</given-names></name><name><surname>Kamiyama</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Nikolskaya</surname><given-names>T</given-names></name><name><surname>Nikolsky</surname><given-names>Y</given-names></name><name><surname>Hartigan</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name><name><surname>Hidalgo</surname><given-names>M</given-names></name><name><surname>Leach</surname><given-names>SD</given-names></name><name><surname>Klein</surname><given-names>AP</given-names></name><name><surname>Jaffee</surname><given-names>EM</given-names></name><name><surname>Goggins</surname><given-names>M</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Iacobuzio-Donahue</surname><given-names>C</given-names></name><name><surname>Eshleman</surname><given-names>JR</given-names></name><name><surname>Kern</surname><given-names>SE</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Core signaling pathways in human pancreatic cancers revealed by global genomic analyses</article-title><source>Science</source><year>2008</year><volume>321</volume><issue>5897</issue><fpage>1801</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.1126/science.1164368</pub-id><?supplied-pmid 18772397?><pub-id pub-id-type="pmid">18772397</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>SW</given-names></name><name><surname>Lin</surname><given-names>AW</given-names></name></person-group><article-title>Apoptosis in cancer</article-title><source>Carcinogenesis</source><year>2000</year><volume>21</volume><issue>3</issue><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1093/carcin/21.3.485</pub-id><?supplied-pmid 10688869?><pub-id pub-id-type="pmid">10688869</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>JA</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Lawrence</surname><given-names>DD</given-names></name><name><surname>Kemp</surname><given-names>BL</given-names></name><name><surname>Carrasco</surname><given-names>CH</given-names></name><name><surname>Ferson</surname><given-names>DZ</given-names></name><name><surname>Hong</surname><given-names>WK</given-names></name><name><surname>Komaki</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Nesbitt</surname><given-names>JC</given-names></name><name><surname>Pisters</surname><given-names>KM</given-names></name><name><surname>Putnam</surname><given-names>JB</given-names></name><name><surname>Schea</surname><given-names>R</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Walsh</surname><given-names>GL</given-names></name><name><surname>Dolormente</surname><given-names>MM</given-names></name><name><surname>Han</surname><given-names>CI</given-names></name><name><surname>Martin</surname><given-names>FD</given-names></name><name><surname>Yen</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Stephens</surname><given-names>LC</given-names></name><name><surname>McDonnell</surname><given-names>TJ</given-names></name><name><surname>Mukhopadhyay</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>D</given-names></name></person-group><article-title>Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><issue>9</issue><fpage>985</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1038/nm0996-985</pub-id><?supplied-pmid 8782455?><pub-id pub-id-type="pmid">8782455</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedi</surname><given-names>A</given-names></name><name><surname>Pasricha</surname><given-names>PJ</given-names></name><name><surname>Akhtar</surname><given-names>AJ</given-names></name><name><surname>Barber</surname><given-names>JP</given-names></name><name><surname>Bedi</surname><given-names>GC</given-names></name><name><surname>Giardiello</surname><given-names>FM</given-names></name><name><surname>Zehnbauer</surname><given-names>BA</given-names></name><name><surname>Hamilton</surname><given-names>SR</given-names></name><name><surname>Jones</surname><given-names>RJ</given-names></name></person-group><article-title>Inhibition of apoptosis during development of colorectal cancer</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><issue>9</issue><fpage>1811</fpage><lpage>1816</lpage><?supplied-pmid 7728743?><pub-id pub-id-type="pmid">7728743</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>SB</given-names></name></person-group><article-title>Resistance to apoptosis in prostate cancer cells</article-title><source>Mol Urol</source><year>2000</year><volume>4</volume><issue>3</issue><fpage>225</fpage><lpage>229</lpage><?supplied-pmid 11062378?><pub-id pub-id-type="pmid">11062378</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockshin</surname><given-names>RA</given-names></name><name><surname>Zakeri</surname><given-names>Z</given-names></name></person-group><article-title>Cell death in health and disease</article-title><source>J Cell Mol Med</source><year>2007</year><volume>11</volume><issue>6</issue><fpage>1214</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2007.00150.x</pub-id><?supplied-pmid 18031301?><pub-id pub-id-type="pmid">18031301</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><issue>5</issue><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><?supplied-pmid 21376230?><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><article-title>The hallmarks of cancer</article-title><source>Cell</source><year>2000</year><volume>100</volume><issue>1</issue><fpage>57</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81683-9</pub-id><?supplied-pmid 10647931?><pub-id pub-id-type="pmid">10647931</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name><name><surname>Gorman</surname><given-names>AM</given-names></name><name><surname>Hori</surname><given-names>O</given-names></name><name><surname>Samali</surname><given-names>A</given-names></name></person-group><article-title>Cellular stress responses: cell survival and cell death</article-title><source>Int J Cell Biol</source><year>2010</year><volume>2010</volume><fpage>214074</fpage><?supplied-pmid 20182529?><pub-id pub-id-type="pmid">20182529</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abate-Shen</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><article-title>Molecular genetics of prostate cancer</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><issue>19</issue><fpage>2410</fpage><lpage>2434</lpage><pub-id pub-id-type="doi">10.1101/gad.819500</pub-id><?supplied-pmid 11018010?><pub-id pub-id-type="pmid">11018010</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grauer</surname><given-names>LS</given-names></name><name><surname>Lawler</surname><given-names>KD</given-names></name><name><surname>Marignac</surname><given-names>JL</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Goel</surname><given-names>AS</given-names></name><name><surname>Wolfert</surname><given-names>RL</given-names></name></person-group><article-title>Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM&#8217; protein in the LNCaP prostatic carcinoma cell line</article-title><source>Cancer Res</source><year>1998</year><volume>58</volume><issue>21</issue><fpage>4787</fpage><lpage>4789</lpage><?supplied-pmid 9809977?><pub-id pub-id-type="pmid">9809977</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiebaut</surname><given-names>F</given-names></name><name><surname>Tsuruo</surname><given-names>T</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Gottesman</surname><given-names>MM</given-names></name><name><surname>Pastan</surname><given-names>I</given-names></name><name><surname>Willingham</surname><given-names>MC</given-names></name></person-group><article-title>Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues</article-title><source>Proc Natl Acad Sci U S A</source><year>1987</year><volume>84</volume><issue>21</issue><fpage>7735</fpage><lpage>7738</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.21.7735</pub-id><?supplied-pmid 2444983?><pub-id pub-id-type="pmid">2444983</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Dunn</surname><given-names>TA</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Isharwal</surname><given-names>S</given-names></name><name><surname>Veltri</surname><given-names>RW</given-names></name><name><surname>Humphreys</surname><given-names>E</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Partin</surname><given-names>AW</given-names></name><name><surname>Vessella</surname><given-names>RL</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name><name><surname>Bova</surname><given-names>GS</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name></person-group><article-title>Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer</article-title><source>Cancer Res</source><year>2009</year><volume>69</volume><issue>1</issue><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-2764</pub-id><?supplied-pmid 19117982?><pub-id pub-id-type="pmid">19117982</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Lentsch</surname><given-names>AB</given-names></name></person-group><article-title>Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines</article-title><source>Am J Physiol Cell Physiol</source><year>2004</year><volume>286</volume><issue>4</issue><fpage>C840</fpage><lpage>C847</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00335.2003</pub-id><?supplied-pmid 14656722?><pub-id pub-id-type="pmid">14656722</pub-id></element-citation></ref></ref-list></back></article>